aluates Reports

$ 0.0

Global Pharmacovigilance Services Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-28S12810

Global Pharmacovigilance Services Market Research Report 2023

BUY CHAPTERS

Global Pharmacovigilance Services Market Research Report 2025

Code: QYRE-Auto-28S12810

Report

March 2025

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Pharmacovigilance Services Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmacovigilance Services Market

The global market for Pharmacovigilance Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance Services.

The Pharmacovigilance Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacovigilance Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmacovigilance Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmacovigilance Services Market Report

Report Metric	Details
Report Name	Pharmacovigilance Services Market
CAGR	5%
Segment by Type	Adverse Event Case Management Aggregate Reporting Signal Intelligence Risk Management
Segment by Application	Biotechnology and Pharmaceuticals Contract Research Organization Hospital KPO / BPO Healthcare Institutions Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PrimeVigilance, Quanticate, ProPharma, Parexel, Accenture, SOTERIUS, SGS, Medpace, PPD, QVigilance, Freyr Solutions, Navitas Life Sciences, MMS Holdings, Amarex, Astrix Technology Group, Cambridge Regulatory Services, CROMSOURCE, APCER Life Sciences, Pharmya, A+Science, Midas Pharma, George Clinical, Syneos Health, INPHARMATIS, Taimei Technology, Extedo, WCG Clinical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmacovigilance Services Market report?

Ans: The main players in the Pharmacovigilance Services Market are PrimeVigilance, Quanticate, ProPharma, Parexel, Accenture, SOTERIUS, SGS, Medpace, PPD, QVigilance, Freyr Solutions, Navitas Life Sciences, MMS Holdings, Amarex, Astrix Technology Group, Cambridge Regulatory Services, CROMSOURCE, APCER Life Sciences, Pharmya, A+Science, Midas Pharma, George Clinical, Syneos Health, INPHARMATIS, Taimei Technology, Extedo, WCG Clinical

What are the Application segmentation covered in the Pharmacovigilance Services Market report?

Ans: The Applications covered in the Pharmacovigilance Services Market report are Biotechnology and Pharmaceuticals, Contract Research Organization, Hospital, KPO / BPO, Healthcare Institutions, Others

What are the Type segmentation covered in the Pharmacovigilance Services Market report?

Ans: The Types covered in the Pharmacovigilance Services Market report are Adverse Event Case Management, Aggregate Reporting, Signal Intelligence, Risk Management

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacovigilance Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Adverse Event Case Management

1.2.3 Aggregate Reporting

1.2.4 Signal Intelligence

1.2.5 Risk Management

1.3 Market by Application

1.3.1 Global Pharmacovigilance Services Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biotechnology and Pharmaceuticals

1.3.3 Contract Research Organization

1.3.4 Hospital

1.3.5 KPO / BPO

1.3.6 Healthcare Institutions

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmacovigilance Services Market Perspective (2020-2031)

2.2 Global Pharmacovigilance Services Growth Trends by Region

2.2.1 Global Pharmacovigilance Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmacovigilance Services Historic Market Size by Region (2020-2025)

2.2.3 Pharmacovigilance Services Forecasted Market Size by Region (2026-2031)

2.3 Pharmacovigilance Services Market Dynamics

2.3.1 Pharmacovigilance Services Industry Trends

2.3.2 Pharmacovigilance Services Market Drivers

2.3.3 Pharmacovigilance Services Market Challenges

2.3.4 Pharmacovigilance Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmacovigilance Services Players by Revenue

3.1.1 Global Top Pharmacovigilance Services Players by Revenue (2020-2025)

3.1.2 Global Pharmacovigilance Services Revenue Market Share by Players (2020-2025)

3.2 Global Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmacovigilance Services Revenue

3.4 Global Pharmacovigilance Services Market Concentration Ratio

3.4.1 Global Pharmacovigilance Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Services Revenue in 2024

3.5 Global Key Players of Pharmacovigilance Services Head office and Area Served

3.6 Global Key Players of Pharmacovigilance Services, Product and Application

3.7 Global Key Players of Pharmacovigilance Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacovigilance Services Breakdown Data by Type

4.1 Global Pharmacovigilance Services Historic Market Size by Type (2020-2025)

4.2 Global Pharmacovigilance Services Forecasted Market Size by Type (2026-2031)

5 Pharmacovigilance Services Breakdown Data by Application

5.1 Global Pharmacovigilance Services Historic Market Size by Application (2020-2025)

5.2 Global Pharmacovigilance Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmacovigilance Services Market Size (2020-2031)

6.2 North America Pharmacovigilance Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmacovigilance Services Market Size by Country (2020-2025)

6.4 North America Pharmacovigilance Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmacovigilance Services Market Size (2020-2031)

7.2 Europe Pharmacovigilance Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmacovigilance Services Market Size by Country (2020-2025)

7.4 Europe Pharmacovigilance Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmacovigilance Services Market Size (2020-2031)

8.2 Asia-Pacific Pharmacovigilance Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmacovigilance Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmacovigilance Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmacovigilance Services Market Size (2020-2031)

9.2 Latin America Pharmacovigilance Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmacovigilance Services Market Size by Country (2020-2025)

9.4 Latin America Pharmacovigilance Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmacovigilance Services Market Size (2020-2031)

10.2 Middle East & Africa Pharmacovigilance Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmacovigilance Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmacovigilance Services Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 PrimeVigilance

11.1.1 PrimeVigilance Company Details

11.1.2 PrimeVigilance Business Overview

11.1.3 PrimeVigilance Pharmacovigilance Services Introduction

11.1.4 PrimeVigilance Revenue in Pharmacovigilance Services Business (2020-2025)

11.1.5 PrimeVigilance Recent Development

11.2 Quanticate

11.2.1 Quanticate Company Details

11.2.2 Quanticate Business Overview

11.2.3 Quanticate Pharmacovigilance Services Introduction

11.2.4 Quanticate Revenue in Pharmacovigilance Services Business (2020-2025)

11.2.5 Quanticate Recent Development

11.3 ProPharma

11.3.1 ProPharma Company Details

11.3.2 ProPharma Business Overview

11.3.3 ProPharma Pharmacovigilance Services Introduction

11.3.4 ProPharma Revenue in Pharmacovigilance Services Business (2020-2025)

11.3.5 ProPharma Recent Development

11.4 Parexel

11.4.1 Parexel Company Details

11.4.2 Parexel Business Overview

11.4.3 Parexel Pharmacovigilance Services Introduction

11.4.4 Parexel Revenue in Pharmacovigilance Services Business (2020-2025)

11.4.5 Parexel Recent Development

11.5 Accenture

11.5.1 Accenture Company Details

11.5.2 Accenture Business Overview

11.5.3 Accenture Pharmacovigilance Services Introduction

11.5.4 Accenture Revenue in Pharmacovigilance Services Business (2020-2025)

11.5.5 Accenture Recent Development

11.6 SOTERIUS

11.6.1 SOTERIUS Company Details

11.6.2 SOTERIUS Business Overview

11.6.3 SOTERIUS Pharmacovigilance Services Introduction

11.6.4 SOTERIUS Revenue in Pharmacovigilance Services Business (2020-2025)

11.6.5 SOTERIUS Recent Development

11.7 SGS

11.7.1 SGS Company Details

11.7.2 SGS Business Overview

11.7.3 SGS Pharmacovigilance Services Introduction

11.7.4 SGS Revenue in Pharmacovigilance Services Business (2020-2025)

11.7.5 SGS Recent Development

11.8 Medpace

11.8.1 Medpace Company Details

11.8.2 Medpace Business Overview

11.8.3 Medpace Pharmacovigilance Services Introduction

11.8.4 Medpace Revenue in Pharmacovigilance Services Business (2020-2025)

11.8.5 Medpace Recent Development

11.9 PPD

11.9.1 PPD Company Details

11.9.2 PPD Business Overview

11.9.3 PPD Pharmacovigilance Services Introduction

11.9.4 PPD Revenue in Pharmacovigilance Services Business (2020-2025)

11.9.5 PPD Recent Development

11.10 QVigilance

11.10.1 QVigilance Company Details

11.10.2 QVigilance Business Overview

11.10.3 QVigilance Pharmacovigilance Services Introduction

11.10.4 QVigilance Revenue in Pharmacovigilance Services Business (2020-2025)

11.10.5 QVigilance Recent Development

11.11 Freyr Solutions

11.11.1 Freyr Solutions Company Details

11.11.2 Freyr Solutions Business Overview

11.11.3 Freyr Solutions Pharmacovigilance Services Introduction

11.11.4 Freyr Solutions Revenue in Pharmacovigilance Services Business (2020-2025)

11.11.5 Freyr Solutions Recent Development

11.12 Navitas Life Sciences

11.12.1 Navitas Life Sciences Company Details

11.12.2 Navitas Life Sciences Business Overview

11.12.3 Navitas Life Sciences Pharmacovigilance Services Introduction

11.12.4 Navitas Life Sciences Revenue in Pharmacovigilance Services Business (2020-2025)

11.12.5 Navitas Life Sciences Recent Development

11.13 MMS Holdings

11.13.1 MMS Holdings Company Details

11.13.2 MMS Holdings Business Overview

11.13.3 MMS Holdings Pharmacovigilance Services Introduction

11.13.4 MMS Holdings Revenue in Pharmacovigilance Services Business (2020-2025)

11.13.5 MMS Holdings Recent Development

11.14 Amarex

11.14.1 Amarex Company Details

11.14.2 Amarex Business Overview

11.14.3 Amarex Pharmacovigilance Services Introduction

11.14.4 Amarex Revenue in Pharmacovigilance Services Business (2020-2025)

11.14.5 Amarex Recent Development

11.15 Astrix Technology Group

11.15.1 Astrix Technology Group Company Details

11.15.2 Astrix Technology Group Business Overview

11.15.3 Astrix Technology Group Pharmacovigilance Services Introduction

11.15.4 Astrix Technology Group Revenue in Pharmacovigilance Services Business (2020-2025)

11.15.5 Astrix Technology Group Recent Development

11.16 Cambridge Regulatory Services

11.16.1 Cambridge Regulatory Services Company Details

11.16.2 Cambridge Regulatory Services Business Overview

11.16.3 Cambridge Regulatory Services Pharmacovigilance Services Introduction

11.16.4 Cambridge Regulatory Services Revenue in Pharmacovigilance Services Business (2020-2025)

11.16.5 Cambridge Regulatory Services Recent Development

11.17 CROMSOURCE

11.17.1 CROMSOURCE Company Details

11.17.2 CROMSOURCE Business Overview

11.17.3 CROMSOURCE Pharmacovigilance Services Introduction

11.17.4 CROMSOURCE Revenue in Pharmacovigilance Services Business (2020-2025)

11.17.5 CROMSOURCE Recent Development

11.18 APCER Life Sciences

11.18.1 APCER Life Sciences Company Details

11.18.2 APCER Life Sciences Business Overview

11.18.3 APCER Life Sciences Pharmacovigilance Services Introduction

11.18.4 APCER Life Sciences Revenue in Pharmacovigilance Services Business (2020-2025)

11.18.5 APCER Life Sciences Recent Development

11.19 Pharmya

11.19.1 Pharmya Company Details

11.19.2 Pharmya Business Overview

11.19.3 Pharmya Pharmacovigilance Services Introduction

11.19.4 Pharmya Revenue in Pharmacovigilance Services Business (2020-2025)

11.19.5 Pharmya Recent Development

11.20 A+Science

11.20.1 A+Science Company Details

11.20.2 A+Science Business Overview

11.20.3 A+Science Pharmacovigilance Services Introduction

11.20.4 A+Science Revenue in Pharmacovigilance Services Business (2020-2025)

11.20.5 A+Science Recent Development

11.21 Midas Pharma

11.21.1 Midas Pharma Company Details

11.21.2 Midas Pharma Business Overview

11.21.3 Midas Pharma Pharmacovigilance Services Introduction

11.21.4 Midas Pharma Revenue in Pharmacovigilance Services Business (2020-2025)

11.21.5 Midas Pharma Recent Development

11.22 George Clinical

11.22.1 George Clinical Company Details

11.22.2 George Clinical Business Overview

11.22.3 George Clinical Pharmacovigilance Services Introduction

11.22.4 George Clinical Revenue in Pharmacovigilance Services Business (2020-2025)

11.22.5 George Clinical Recent Development

11.23 Syneos Health

11.23.1 Syneos Health Company Details

11.23.2 Syneos Health Business Overview

11.23.3 Syneos Health Pharmacovigilance Services Introduction

11.23.4 Syneos Health Revenue in Pharmacovigilance Services Business (2020-2025)

11.23.5 Syneos Health Recent Development

11.24 INPHARMATIS

11.24.1 INPHARMATIS Company Details

11.24.2 INPHARMATIS Business Overview

11.24.3 INPHARMATIS Pharmacovigilance Services Introduction

11.24.4 INPHARMATIS Revenue in Pharmacovigilance Services Business (2020-2025)

11.24.5 INPHARMATIS Recent Development

11.25 Taimei Technology

11.25.1 Taimei Technology Company Details

11.25.2 Taimei Technology Business Overview

11.25.3 Taimei Technology Pharmacovigilance Services Introduction

11.25.4 Taimei Technology Revenue in Pharmacovigilance Services Business (2020-2025)

11.25.5 Taimei Technology Recent Development

11.26 Extedo

11.26.1 Extedo Company Details

11.26.2 Extedo Business Overview

11.26.3 Extedo Pharmacovigilance Services Introduction

11.26.4 Extedo Revenue in Pharmacovigilance Services Business (2020-2025)

11.26.5 Extedo Recent Development

11.27 WCG Clinical

11.27.1 WCG Clinical Company Details

11.27.2 WCG Clinical Business Overview

11.27.3 WCG Clinical Pharmacovigilance Services Introduction

11.27.4 WCG Clinical Revenue in Pharmacovigilance Services Business (2020-2025)

11.27.5 WCG Clinical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Pharmacovigilance Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Adverse Event Case Management

Table 3. Key Players of Aggregate Reporting

Table 4. Key Players of Signal Intelligence

Table 5. Key Players of Risk Management

Table 6. Global Pharmacovigilance Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pharmacovigilance Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Pharmacovigilance Services Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Pharmacovigilance Services Market Share by Region (2020-2025)

Table 10. Global Pharmacovigilance Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Pharmacovigilance Services Market Share by Region (2026-2031)

Table 12. Pharmacovigilance Services Market Trends

Table 13. Pharmacovigilance Services Market Drivers

Table 14. Pharmacovigilance Services Market Challenges

Table 15. Pharmacovigilance Services Market Restraints

Table 16. Global Pharmacovigilance Services Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Pharmacovigilance Services Market Share by Players (2020-2025)

Table 18. Global Top Pharmacovigilance Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Services as of 2024)

Table 19. Ranking of Global Top Pharmacovigilance Services Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Pharmacovigilance Services Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Pharmacovigilance Services, Headquarters and Area Served

Table 22. Global Key Players of Pharmacovigilance Services, Product and Application

Table 23. Global Key Players of Pharmacovigilance Services, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Pharmacovigilance Services Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Pharmacovigilance Services Revenue Market Share by Type (2020-2025)

Table 27. Global Pharmacovigilance Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Pharmacovigilance Services Revenue Market Share by Type (2026-2031)

Table 29. Global Pharmacovigilance Services Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Pharmacovigilance Services Revenue Market Share by Application (2020-2025)

Table 31. Global Pharmacovigilance Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Pharmacovigilance Services Revenue Market Share by Application (2026-2031)

Table 33. North America Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Pharmacovigilance Services Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Pharmacovigilance Services Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Pharmacovigilance Services Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Pharmacovigilance Services Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Pharmacovigilance Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Pharmacovigilance Services Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Pharmacovigilance Services Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Pharmacovigilance Services Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pharmacovigilance Services Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Pharmacovigilance Services Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Pharmacovigilance Services Market Size by Country (2026-2031) & (US$ Million)

Table 48. PrimeVigilance Company Details

Table 49. PrimeVigilance Business Overview

Table 50. PrimeVigilance Pharmacovigilance Services Product

Table 51. PrimeVigilance Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 52. PrimeVigilance Recent Development

Table 53. Quanticate Company Details

Table 54. Quanticate Business Overview

Table 55. Quanticate Pharmacovigilance Services Product

Table 56. Quanticate Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 57. Quanticate Recent Development

Table 58. ProPharma Company Details

Table 59. ProPharma Business Overview

Table 60. ProPharma Pharmacovigilance Services Product

Table 61. ProPharma Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 62. ProPharma Recent Development

Table 63. Parexel Company Details

Table 64. Parexel Business Overview

Table 65. Parexel Pharmacovigilance Services Product

Table 66. Parexel Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 67. Parexel Recent Development

Table 68. Accenture Company Details

Table 69. Accenture Business Overview

Table 70. Accenture Pharmacovigilance Services Product

Table 71. Accenture Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 72. Accenture Recent Development

Table 73. SOTERIUS Company Details

Table 74. SOTERIUS Business Overview

Table 75. SOTERIUS Pharmacovigilance Services Product

Table 76. SOTERIUS Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 77. SOTERIUS Recent Development

Table 78. SGS Company Details

Table 79. SGS Business Overview

Table 80. SGS Pharmacovigilance Services Product

Table 81. SGS Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 82. SGS Recent Development

Table 83. Medpace Company Details

Table 84. Medpace Business Overview

Table 85. Medpace Pharmacovigilance Services Product

Table 86. Medpace Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 87. Medpace Recent Development

Table 88. PPD Company Details

Table 89. PPD Business Overview

Table 90. PPD Pharmacovigilance Services Product

Table 91. PPD Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 92. PPD Recent Development

Table 93. QVigilance Company Details

Table 94. QVigilance Business Overview

Table 95. QVigilance Pharmacovigilance Services Product

Table 96. QVigilance Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 97. QVigilance Recent Development

Table 98. Freyr Solutions Company Details

Table 99. Freyr Solutions Business Overview

Table 100. Freyr Solutions Pharmacovigilance Services Product

Table 101. Freyr Solutions Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 102. Freyr Solutions Recent Development

Table 103. Navitas Life Sciences Company Details

Table 104. Navitas Life Sciences Business Overview

Table 105. Navitas Life Sciences Pharmacovigilance Services Product

Table 106. Navitas Life Sciences Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 107. Navitas Life Sciences Recent Development

Table 108. MMS Holdings Company Details

Table 109. MMS Holdings Business Overview

Table 110. MMS Holdings Pharmacovigilance Services Product

Table 111. MMS Holdings Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 112. MMS Holdings Recent Development

Table 113. Amarex Company Details

Table 114. Amarex Business Overview

Table 115. Amarex Pharmacovigilance Services Product

Table 116. Amarex Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 117. Amarex Recent Development

Table 118. Astrix Technology Group Company Details

Table 119. Astrix Technology Group Business Overview

Table 120. Astrix Technology Group Pharmacovigilance Services Product

Table 121. Astrix Technology Group Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 122. Astrix Technology Group Recent Development

Table 123. Cambridge Regulatory Services Company Details

Table 124. Cambridge Regulatory Services Business Overview

Table 125. Cambridge Regulatory Services Pharmacovigilance Services Product

Table 126. Cambridge Regulatory Services Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 127. Cambridge Regulatory Services Recent Development

Table 128. CROMSOURCE Company Details

Table 129. CROMSOURCE Business Overview

Table 130. CROMSOURCE Pharmacovigilance Services Product

Table 131. CROMSOURCE Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 132. CROMSOURCE Recent Development

Table 133. APCER Life Sciences Company Details

Table 134. APCER Life Sciences Business Overview

Table 135. APCER Life Sciences Pharmacovigilance Services Product

Table 136. APCER Life Sciences Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 137. APCER Life Sciences Recent Development

Table 138. Pharmya Company Details

Table 139. Pharmya Business Overview

Table 140. Pharmya Pharmacovigilance Services Product

Table 141. Pharmya Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 142. Pharmya Recent Development

Table 143. A+Science Company Details

Table 144. A+Science Business Overview

Table 145. A+Science Pharmacovigilance Services Product

Table 146. A+Science Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 147. A+Science Recent Development

Table 148. Midas Pharma Company Details

Table 149. Midas Pharma Business Overview

Table 150. Midas Pharma Pharmacovigilance Services Product

Table 151. Midas Pharma Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 152. Midas Pharma Recent Development

Table 153. George Clinical Company Details

Table 154. George Clinical Business Overview

Table 155. George Clinical Pharmacovigilance Services Product

Table 156. George Clinical Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 157. George Clinical Recent Development

Table 158. Syneos Health Company Details

Table 159. Syneos Health Business Overview

Table 160. Syneos Health Pharmacovigilance Services Product

Table 161. Syneos Health Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 162. Syneos Health Recent Development

Table 163. INPHARMATIS Company Details

Table 164. INPHARMATIS Business Overview

Table 165. INPHARMATIS Pharmacovigilance Services Product

Table 166. INPHARMATIS Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 167. INPHARMATIS Recent Development

Table 168. Taimei Technology Company Details

Table 169. Taimei Technology Business Overview

Table 170. Taimei Technology Pharmacovigilance Services Product

Table 171. Taimei Technology Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 172. Taimei Technology Recent Development

Table 173. Extedo Company Details

Table 174. Extedo Business Overview

Table 175. Extedo Pharmacovigilance Services Product

Table 176. Extedo Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 177. Extedo Recent Development

Table 178. WCG Clinical Company Details

Table 179. WCG Clinical Business Overview

Table 180. WCG Clinical Pharmacovigilance Services Product

Table 181. WCG Clinical Revenue in Pharmacovigilance Services Business (2020-2025) & (US$ Million)

Table 182. WCG Clinical Recent Development

Table 183. Research Programs/Design for This Report

Table 184. Key Data Information from Secondary Sources

Table 185. Key Data Information from Primary Sources

Table 186. Authors List of This Report

List of Figures

Figure 1. Pharmacovigilance Services Picture

Figure 2. Global Pharmacovigilance Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmacovigilance Services Market Share by Type: 2024 VS 2031

Figure 4. Adverse Event Case Management Features

Figure 5. Aggregate Reporting Features

Figure 6. Signal Intelligence Features

Figure 7. Risk Management Features

Figure 8. Global Pharmacovigilance Services Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Pharmacovigilance Services Market Share by Application: 2024 VS 2031

Figure 10. Biotechnology and Pharmaceuticals Case Studies

Figure 11. Contract Research Organization Case Studies

Figure 12. Hospital Case Studies

Figure 13. KPO / BPO Case Studies

Figure 14. Healthcare Institutions Case Studies

Figure 15. Others Case Studies

Figure 16. Pharmacovigilance Services Report Years Considered

Figure 17. Global Pharmacovigilance Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Pharmacovigilance Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Pharmacovigilance Services Market Share by Region: 2024 VS 2031

Figure 20. Global Pharmacovigilance Services Market Share by Players in 2024

Figure 21. Global Top Pharmacovigilance Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Services as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Pharmacovigilance Services Revenue in 2024

Figure 23. North America Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Pharmacovigilance Services Market Share by Country (2020-2031)

Figure 25. United States Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Pharmacovigilance Services Market Share by Country (2020-2031)

Figure 29. Germany Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Pharmacovigilance Services Market Share by Region (2020-2031)

Figure 37. China Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Pharmacovigilance Services Market Share by Country (2020-2031)

Figure 45. Mexico Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Pharmacovigilance Services Market Share by Country (2020-2031)

Figure 49. Turkey Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Pharmacovigilance Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. PrimeVigilance Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 53. Quanticate Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 54. ProPharma Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 55. Parexel Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 56. Accenture Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 57. SOTERIUS Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 58. SGS Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 59. Medpace Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 60. PPD Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 61. QVigilance Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 62. Freyr Solutions Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 63. Navitas Life Sciences Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 64. MMS Holdings Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 65. Amarex Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 66. Astrix Technology Group Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 67. Cambridge Regulatory Services Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 68. CROMSOURCE Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 69. APCER Life Sciences Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 70. Pharmya Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 71. A+Science Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 72. Midas Pharma Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 73. George Clinical Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 74. Syneos Health Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 75. INPHARMATIS Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 76. Taimei Technology Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 77. Extedo Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 78. WCG Clinical Revenue Growth Rate in Pharmacovigilance Services Business (2020-2025)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pharmacovigilance Services Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-28S12810

Global Pharmacovigilance Services Market Research Report 2025

FEATURED COMPANIES

Pharmacovigilance Services Market Size

Pharmacovigilance Services Market

Scope of Pharmacovigilance Services Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Pharmacovigilance Services Market report?

What are the Application segmentation covered in the Pharmacovigilance Services Market report?

What are the Type segmentation covered in the Pharmacovigilance Services Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User